908 Devices (NASDAQ:MASS) SVP Kevin Mccallion Sells 18,580 Shares

Key Points

• Insider sale: SVP Kevin Mccallion sold 18,580 shares at an average price of $7.05 under a pre‑arranged Rule 10b5‑1 plan, generating $130,989 and reducing his stake by 29.26% to 44,925 shares.
• Recent results and stock action: 908 Devices reported Q1 EPS of ($0.05) beating estimates and revenue of $17.38M, and the stock traded up about 2.6% to $7.14 (market cap ~$266.9M; 52‑week range $3.79–$9.34).
• Institutional backing vs. analyst view: Institutional investors own 88.06% after several firms materially increased positions, while Wall Street’s consensus is a "Hold" (one Buy, one Sell) with a $12 target.

908 Devices Inc. (NASDAQ:MASS - Get Free Report) SVP Kevin Mccallion sold 18,580 shares of the stock in a transaction on Wednesday, April 8th. The stock was sold at an average price of $7.05, for a total value of $130,989.00. Following the completion of the sale, the senior vice president directly owned 44,925 shares in the company, valued at $316,721.25. This represents a 29.26% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

908 Devices Stock Up 2.6%

NASDAQ MASS traded up $0.18 during trading hours on Friday, hitting $7.14. The company had a trading volume of 244,540 shares, compared to its average volume of 254,609. 908 Devices Inc. has a fifty-two week low of $3.79 and a fifty-two week high of $9.34. The business has a fifty day simple moving average of $6.47 and a 200-day simple moving average of $6.67. The firm has a market cap of $266.89 million, a P/E ratio of 12.98 and a beta of 0.54.

908 Devices (NASDAQ:MASS - Get Free Report) last issued its earnings results on Tuesday, March 3rd. The company reported ($0.05) earnings per share for the quarter, topping the consensus estimate of ($0.06) by $0.01. 908 Devices had a negative return on equity of 14.99% and a net margin of 34.68%.The firm had revenue of $17.38 million for the quarter, compared to analyst estimates of $16.19 million. Equities analysts forecast that 908 Devices Inc. will post -1.99 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. First Light Asset Management LLC boosted its stake in 908 Devices by 92.6% during the fourth quarter. First Light Asset Management LLC now owns 4,836,186 shares of the company's stock valued at $25,390,000 after buying an additional 2,325,690 shares in the last quarter. Needham Investment Management LLC boosted its stake in 908 Devices by 246.8% during the fourth quarter. Needham Investment Management LLC now owns 770,000 shares of the company's stock valued at $4,042,000 after buying an additional 548,000 shares in the last quarter. Marshall Wace LLP boosted its stake in 908 Devices by 359.4% during the second quarter. Marshall Wace LLP now owns 648,796 shares of the company's stock valued at $4,626,000 after buying an additional 507,562 shares in the last quarter. First Eagle Investment Management LLC boosted its stake in 908 Devices by 125.9% during the third quarter. First Eagle Investment Management LLC now owns 603,962 shares of the company's stock valued at $5,291,000 after buying an additional 336,584 shares in the last quarter. Finally, Bank of America Corp DE boosted its stake in 908 Devices by 221.7% during the second quarter. Bank of America Corp DE now owns 363,217 shares of the company's stock valued at $2,590,000 after buying an additional 250,311 shares in the last quarter. Institutional investors own 88.06% of the company's stock.

Wall Street Analyst Weigh In

MASS has been the subject of several recent analyst reports. Weiss Ratings reissued a "sell (d-)" rating on shares of 908 Devices in a research note on Wednesday, January 21st. Wall Street Zen raised 908 Devices from a "hold" rating to a "buy" rating in a research note on Saturday, March 14th. One analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $12.00.

About 908 Devices

908 Devices Inc NASDAQ: MASS is a developer and manufacturer of portable analytical instruments designed to deliver rapid chemical detection in field and laboratory environments. The company's core focus lies in miniaturizing high-performance mass spectrometry and ion mobility spectrometry technologies, enabling users to perform on-site analysis that traditionally required benchtop equipment.

Key products in 908 Devices' portfolio include the MX908, a handheld high-resolution mass spectrometer capable of detecting and identifying a broad range of chemicals and explosives; the M908 portable mass spectrometer for laboratory or mobile units; and the ZipChip capillary electrophoresis system for high-throughput, microfluidic separations.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.